From leeches to personalized medicine: evolving concepts in the management of polycythemia vera.
about
Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.Hemochromatosis, Erythrocytosis and the JAK2 p.V617F Mutation.Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia.Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial
P2860
From leeches to personalized medicine: evolving concepts in the management of polycythemia vera.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
From leeches to personalized m ...... nagement of polycythemia vera.
@en
From leeches to personalized m ...... nagement of polycythemia vera.
@nl
type
label
From leeches to personalized m ...... nagement of polycythemia vera.
@en
From leeches to personalized m ...... nagement of polycythemia vera.
@nl
prefLabel
From leeches to personalized m ...... nagement of polycythemia vera.
@en
From leeches to personalized m ...... nagement of polycythemia vera.
@nl
P2860
P1433
P1476
From leeches to personalized m ...... nagement of polycythemia vera.
@en
P2093
Alessandro M Vannucchi
P2860
P356
10.3324/HAEMATOL.2015.129155
P577
2016-11-24T00:00:00Z